This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Fenfen Chen: Innovator in Pharmaceutical Development
Introduction
Fenfen Chen is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for metabolic disorders. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Fenfen Chen holds 2 patents that focus on GLP-1 receptor agonists. His latest patents include a crystalline form A of a GLP-1 receptor agonist and a preparation method for it. This invention relates to a crystal form A of a specific compound, which may be beneficial in treating various conditions, including type 2 diabetes. Additionally, he has developed pharmaceutically acceptable acid salts of the same compound, which also aim to address metabolic disorders.
Career Highlights
Fenfen Chen is currently employed at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. His work at this company has allowed him to collaborate with other talented professionals in the pharmaceutical industry. His contributions have been instrumental in the development of new therapeutic options for patients.
Collaborations
Fenfen Chen has worked alongside colleagues such as Haiwen Hu and Li Fang. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.
Conclusion
Fenfen Chen's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to improving treatments for metabolic disorders. Through his efforts, he continues to contribute to advancements in medical science.